AUROBINDO PHARMA
Back to Balance Sheet
|
AUROBINDO PHARMA Last 5 Year Long Term Provisions History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Long Term Provisions | ₹283 Cr | ₹226 Cr | ₹173 Cr | ₹172 Cr | ₹157 Cr |
What is the latest Long Term Provisions ratio of AUROBINDO PHARMA ?
| Year | Long Term Provisions |
|---|---|
| Mar2025 | ₹283 Cr |
| Mar2024 | ₹226 Cr |
| Mar2023 | ₹173 Cr |
| Mar2022 | ₹172 Cr |
| Mar2021 | ₹157 Cr |
How is Long Term Provisions of AUROBINDO PHARMA Trending?
| Years | Long Term Provisions | % Change | |
|---|---|---|---|
| Mar2025 | ₹283 Cr | 25.36 | |
| Mar2024 | ₹226 Cr | 30.67 | |
| Mar2023 | ₹173 Cr | 0.54 | |
| Mar2022 | ₹172 Cr | 9.34 | |
| Mar2021 | ₹157 Cr | - | |
Compare Long Term Provisions of peers of AUROBINDO PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| AUROBINDO PHARMA | ₹70,041.6 Cr | -1.5% | -1.9% | -3.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹412,494.0 Cr | -1.5% | -4.8% | -4.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹170,514.0 Cr | -0.9% | -1.4% | 11.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹129,044.0 Cr | 0.3% | 1.6% | 12.1% | Stock Analytics | |
| CIPLA | ₹121,574.0 Cr | -0.8% | -1.2% | 1.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹105,919.0 Cr | -0.8% | 1.7% | -5.6% | Stock Analytics | |
AUROBINDO PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AUROBINDO PHARMA | -1.5% |
-1.9% |
-3.2% |
| SENSEX | 0.7% |
0.5% |
9% |
You may also like the below Video Courses